Co-immunoprecipitation (co-IP) assays confirmed that both ectopically expressed and endogenous SPOP interacted with Geminin in 293T cells and PC-3 prostate cancer cells (Fig. 1d, e and Supplementary Fig. 1j). This evidence concerns the gene GMNN and prostate carcinoma.